NeoGenomics is trading at $15.62, down 4.7%, in pre-market; broader risk-off sentiment may be a factor.
- No company-specific announcement explaining the move appeared in available company news; the latest listed releases were dated October 15.
- Reuters reported lower futures amid caution after an AI-linked stock selloff; the supplied market context shows the Dow down 0.83%.
- NeoGenomics is scheduled to report third-quarter results on October 28.